|Articles|January 28, 2013
Healthcare Among the Early Leaders as 'Obamacare' Starts to Become a Reality
Advertisement
NEW YORK — Health care stocks have started off the year on a tear.
The industry group that includes health care providers, drugmakers and biotechnology companies has advanced 7.3 percent this year, making it the second-best in the Standard and Poor’s 500 index, trailing only energy companies. Even drugmakers, traditionally considered a safe-haven play, are outperforming the market.
Read the full story:
Source: The Washington Post
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
